Progenics Pharmaceuticals Announces Fourth Quarter and Year-End 2014 Financial Results

Go back to Progenics Pharmaceuticals Announces Fourth Quarter and Year-End 2014 Financial Results

Progenics Pharma (PGNX) Misses Q4 EPS by 5c

March 16, 2015 8:10 AM EDT

Progenics Pharma (NASDAQ: PGNX) reported Q4 EPS of ($0.18), $0.05 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Progenics Pharma (PGNX) click here.

... More